about
Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic markerChimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteCommon variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSevere alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadridThe first European interdisciplinary ewing sarcoma research summitTargeting DAX-1 in embryonic stem cells and cancer.DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders.Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer.DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibilityFrequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationships
P50
Q21261242-336D0410-D92F-457B-826B-13A910F1E0C2Q22122062-79716E74-F5AC-4A18-B384-72240DF4B154Q29028729-D993A66C-7315-4629-838B-816E37D201A7Q34325994-A742B74D-7457-4C6B-9DEB-A893860C0253Q35993560-1E2406FE-83F0-4CBB-8686-996BC89A4E33Q37670246-73E5C2B5-723B-4EAA-AD49-023017A97EE3Q38289673-BDFF01B2-AC0F-4EB6-A4F5-04E1DF92B067Q38320273-2F0820E7-1696-419F-AB03-69743578474BQ38439891-60BF9938-6E37-4183-B1BB-4AB744F6C922Q38696838-09406978-E1CE-4602-8C5D-05132665EF71Q39634845-67AA5AF6-C99F-4B2A-9DF6-157B75C1AE70Q40039502-C36F83F0-8616-4CDC-8768-C60D37D5B075Q41717727-1152C10A-2FE1-4955-A43B-6878D4DD63EEQ47726410-57CD3250-B230-4E40-A8E9-A5D86E06E82FQ51335083-422EFA70-55C5-43F5-9CD9-D59EF2AC3ED2Q56346041-37FCED71-39AA-4810-AC14-FDB74AD6CDE6Q91474417-52B55CEB-BB11-4D0E-9DC6-B80D3CE78BC7
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Javier Alonso
@ast
Javier Alonso
@en
Javier Alonso
@en-gb
Javier Alonso
@es
Javier Alonso
@nl
Javier Alonso
@sl
type
label
Javier Alonso
@ast
Javier Alonso
@en
Javier Alonso
@en-gb
Javier Alonso
@es
Javier Alonso
@nl
Javier Alonso
@sl
altLabel
J Alonso
@en
prefLabel
Javier Alonso
@ast
Javier Alonso
@en
Javier Alonso
@en-gb
Javier Alonso
@es
Javier Alonso
@nl
Javier Alonso
@sl
P106
P21
P31
P496
0000-0002-6287-8391